Crossmark

7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders

Published Online: 2016-01-06

Published Print: 2016-12

Authors

Liu, Chaoyang

Chan, Chi Bun

Ye, Keqiang
Funding

Funding for this research was provided by:

National Institutes of Health (NS045627)
License Information

Text and Data Mining valid from 2016-01-06

Version of Record valid from 2016-01-06
More Information

Article History

Received: 30 September 2015

Accepted: 29 December 2015

First Online: 6 January 2016

Document is current